Randomized phase Ib/II study of PF-05212384 plus 5-fluorouracil-leucovorin-irinotecan (FOLFIRI) versus bevacizumab plus FOLFIRI in metastatic colorectal cancer (B2151007; NCT01937715).
Zev A. Wainberg
Research Funding - Pfizer
Nicoletta Brega
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Craig Davis
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Ashwin Gollerkeri
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Kristen J. Pierce
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Mie Suzuki
Employment or Leadership Position - Pfizer (B)
Rachelle Perea
Employment or Leadership Position - Pfizer